OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston SummitBusiness Wire • 05/13/25
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate ProgramGlobeNewsWire • 05/05/25
OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business HighlightsBusiness Wire • 03/18/25
OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics ConferenceBusiness Wire • 12/16/24
Long Assets On Path To Creating Significant Value, Shorting Remains Very ChallengingSeeking Alpha • 08/06/24